Douglas Lane & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $337K | Hold |
|
|||||
|
2024
Q4 | $418K | Buy |
|
|||||
|
2024
Q3 | $572K | Hold |
|
|||||
|
2024
Q2 | $686K | Buy |
|
|||||
|
2024
Q1 | $609K | Hold |
|
|||||
|
2023
Q4 | $491K | Sell |
|
|||||
|
2023
Q3 | $449K | Sell |
|
|||||
|
2023
Q2 | $408K | Hold |
|
|||||
|
2023
Q1 | $401K | Sell |
|
|||||
|
2022
Q4 | $347K | Sell |
|
|||||
|
2022
Q3 | $323K | Sell |
|
|||||
|
2022
Q2 | $378K | Hold |
|
|||||
|
2022
Q1 | $377K | Sell |
|
|||||
|
2021
Q4 | $384K | Sell |
|
|||||
|
2021
Q3 | $336K | Hold |
|
|||||
|
2021
Q2 | $294K | Sell |
|
|||||
|
2021
Q1 | $260K | Sell |
|
|||||
|
2020
Q4 | $273K | Buy |
|
|||||
|
2020
Q3 | $268K | Sell |
|
|||||
|
2020
Q2 | $264K | Buy |
|
|||||
|
2020
Q1 | $211K | Sell |
|
|||||
|
2019
Q4 | $383K | Buy |
|
|||||
|
2019
Q3 | $331K | Hold |
|
|||||
|
2019
Q2 | $327K | Sell |
|
|||||
|
2019
Q1 | $429K | Hold |
|
|||||
|
2018
Q4 | $378K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $354K | Sell |
|
|||||
|
2017
Q2 | $1.07M | Sell |
|
|||||
|
2017
Q1 | $1.38M | Sell |
|
|||||
|
2016
Q4 | $2.45M | Sell |
|
|||||
|
2016
Q3 | $6.75M | Sell |
|
|||||
|
2016
Q2 | $13M | Sell |
|
|||||
|
2016
Q1 | $16.2M | Buy |
|